SCHEMBL21161191

SCHEMBL21161191

Cc1ccc(S(=O)OCCCCCCCCNC(=O)OC(C)(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.49
CA1 P00915 6/20 0.49
CA2 P00918 6/20 0.49
CA9 Q16790 6/20 0.49
TDP1 Q9NUW8 2/20 0.49
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
RECQL P46063 1/20 0.43
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
BRD4 O60885 2/20 0.42
MAPT P10636 2/20 0.42
TP53 P04637 2/20 0.41
TSHR P16473 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21161629 1.00 CA12 (0.49) CA12CA1CA2CA9TDP1
SCHEMBL21161661 1.00 CA12 (0.49) CA12CA1CA2CA9TDP1
SCHEMBL14313674 0.79 CA12 (0.70) CA12CA1CA2CA9TDP1
SCHEMBL18360003 0.77 TDP1 (0.56) CA12CA1CA2CA9TDP1
SCHEMBL20058924 0.77 CA12 (0.53) CA12CA1CA2CA9TDP1
SCHEMBL25718673 0.77 CA12 (0.53) CA12CA1CA2CA9TDP1
SCHEMBL23835564 0.76 CA1 (0.61) CA12CA1CA2CA9TDP1
SCHEMBL29040473 0.76 CA1 (0.61) CA12CA1CA2CA9TDP1
SCHEMBL16930099 0.76 CA1 (0.61) CA12CA1CA2CA9TDP1
SCHEMBL4640090 0.76 CA1 (0.61) CA12CA1CA2CA9TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3292120-B1 TETRAHYDROPYRIDOPYRIMIDINES AND TETRAHYDROPYRIDOPYRIDINES AS INHIBITORS OF HBSAG (HBV SURFACE ANTIGEN) AND HBV DNA PRODUCTION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS HOFFMANN LA ROCHE (CH) 2019-06-19 EP disclosed